fda warning letter glp-1 solution september 2025 warns Novo Nordisk over unreported Ozempic and Wegovy side effects Medicare's New GLP-1 Pricing Initiative

Omeprazole was identified as the most cost-effective PPI in this study

Some of the acetylcarnitine was incorporated into saturated fatty acids (about 60% of the radioactivity present in the tissues), but it was also found in monounsaturated fatty acids and PUFAs (polyunsaturated fatty acids)

The marketing environment after April 22 is the most likely near-term enforcement zone

In April 2026, The Foundation for Prader-Willi Research (FPWR) announced a venture philanthropy investment in ConSynance Therapeutics to support the advancement of CSTI-500, ConSynance s investigational therapy for the treatment of behavioral dysregulation and hyperphagia in PWS

New VA data from over 600,000 individuals with type 2 diabetes shows GLP-1 receptor agonist use was associated with a lower risk of developing a substance use disorder